Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2025 04:54 ET | Source: Research and Markets

Oncology NGS Market Research, 2024 & 2025-2029: Integration with AI and Bioinformatics, Increased Focus on Personalized Medicine, Decentralization of NGS Testing

Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Oncology NGS Market: Analysis By Technology, By Workflow, By Application, By End User, By Region Size and Trends - Forecast up to 2029" report has been...
November 18, 2024 10:20 ET | Source: Research and Markets

10 year 8 Major Market Bladder Cancer Epidemiology Forecasts 2023-2033

Dublin, Nov. 18, 2024 (GLOBE NEWSWIRE) -- The "Bladder Cancer: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.Bladder cancer (International Classification...
August 11, 2021 04:48 ET | Source: Research and Markets

Global DNA/RNA Extraction Kit Market Research Report 2021-2026: Increasing Investments in Research and Development of Molecular Diagnostics Driving Growth

Dublin, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The "DNA/RNA Extraction Kit Market - Growth, Trends, COVID-19 Impact, and Forecast (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
July 05, 2021 06:53 ET | Source: Research and Markets

Circulating DNA/RNA Patent Landscape Report 2021: Oppositions and Litigations, Key Patent Analysis, Patent Database

Dublin, July 05, 2021 (GLOBE NEWSWIRE) -- The "Circulating DNA/RNA Patent Landscape 2021" report has been added to ResearchAndMarkets.com's offering. Circulating nucleic acids tests, an essential...
June 22, 2020 09:32 ET | Source: Inivata

Inivata to Present Data at AACR Virtual Annual Meeting Highlighting Capabilities and Clinical Application of RaDaR™ Assay

Inivata to Present Data at AACR Virtual Annual Meeting Highlighting Capabilities and Clinical Application of RaDaR™ Assay Personalized assay for detection of residual disease and recurrence...
October 16, 2018 07:47 ET | Source: Precipio, Inc.

Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues

Fourth consecutive Quarter of Triple-Digit Year-over-Year Quarterly Revenue Growth; Year-to-Date Revenues Increased 163% over First Three Quarters of 2017 NEW HAVEN, Conn., Oct. 16, 2018 (GLOBE...
June 06, 2018 07:38 ET | Source: Precipio, Inc.

Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology

NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR...
August 09, 2017 09:02 ET | Source: Exosome Diagnostics

Exosome Diagnostics Launches the MedOncAlyzer™ Pan-Cancer Panel

Waltham, Mass., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, a leader in the liquid biopsy market, today announced the launch of the MedOncAlyzer 170, the first liquid biopsy pan-cancer...
November 05, 2015 15:18 ET | Source: ARUP Laboratories

Breakthrough Technology Spurs New Test for Non-Small Cell Lung Cancer Patients

SALT LAKE CITY, Nov. 5, 2015 (GLOBE NEWSWIRE) -- For a patient battling lung cancer, the discomforts and risks of undergoing repeated biopsies, surgeries, and radiologic scans can now be replaced by a...